InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: stockguard post# 136

Sunday, 05/09/2021 6:43:53 PM

Sunday, May 09, 2021 6:43:53 PM

Post# of 247
At ASGCT they might show that their HiT targeting mesothelin has advantages over a comparative TRuC construct (similar to TCRR's) that was developed in-house.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News